Reduced Aph‐1b expression causes tissue‐ and substrate‐specific changes in γ‐secretase activity in rats with a complex phenotype-Reference-Cited by-同舟云学术

Reduced Aph‐1b expression causes tissue‐ and substrate‐specific changes in γ‐secretase activity in rats with a complex phenotype

Published:2005-10-25 Issue:1 Volume:20 Page:175-177
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Coolen Marcel W.¹,Loo Karen M. J.¹,Bakel Nick N. H. M.¹,Ellenbroek Bart A.²,Cools Alexander R.²,Martens Gerard J. M.¹

Affiliation:

1. Department of Molecular Animal PhysiologyNijmegen Center for Molecular Life Sciences (NCMLS) and Institute for NeuroscienceRadboud University of Nijmegen St. Radboud Nijmegen The Netherlands

2. Department of PsychoneuropharmacologyUMC St. Radboud Nijmegen The Netherlands

Funder

Netherlands Organization for International Cooperation in Higher Education

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.05-4337fje

Reference47 articles.

1. γ-Secretase: proteasome of the membrane?

2. Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic Perspective

3. γ-Secretase-mediated proteolysis in cell-surface-receptor signalling

4. gamma‐Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in? Nat;Sisodia S. S.;Rev. Neurosci,2002

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Membrane dynamics of γ‐secretase with the anterior pharynx‐defective 1B subunit;Journal of Cellular Biochemistry;2020-08-23

2. Interneuron hypomyelination is associated with cognitive inflexibility in a rat model of schizophrenia;Nature Communications;2020-05-11

3. Alzheimer’s Disease Genetics: Review of Novel Loci Associated with Disease;Current Genetic Medicine Reports;2020-02-04

4. Negative evidence for a role of APH1B T27I variant in Alzheimer’s disease;Human Molecular Genetics;2020-01-29

5. γ-Secretase Inhibitors: From Chemical Probes to Drug Development;Developing Therapeutics for Alzheimer's Disease;2016